Skip to main content
. 2021 Jul 13;39(35):4932–4937. doi: 10.1016/j.vaccine.2021.07.007

Table 2.

Types of support sampled manufacturers require for the listed processes.

Type of support required (%)
Assessed manufacturing processes Tech Transfer Training Funding
Drug Substance 70% 70% 74%
Drug Product 63% 63% 63%
Supply 48% 52%
Clinical Trials 44% 81%
Regulatory 85% 44%

Percentage of the sampled manufacturers requiring the given type of support for each manufacturing process assessed.

Respondents were able to select any number of the listed support mechanisms.